ARCHIVES

FDA Vs. NCI: Nothing Has Changed; Chabner “Frustrated” By Flutamide Delay

This article is from The Cancer Letter archive.

Vol. 14 No. 41 | October 21, 1988

Download PDF Visit The Full Archive

Related Articles

Five-Fold Increase in Chordoma Risk Linked to Common Gene Variant

October 26, 2012

Digital Microscope Blood Test Identifies Circulating Tumor Cells

February 24, 2012

“Miracle-Gro for Cancer?” ODAC Members Vent At Amgen And J&J Over Claims, Advertising.

May 18, 2007

Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President.

March 23, 2007

NCI To Offer Advice On Unconventional Therapy. Not Funds

December 14, 1990

Wistar’s Koprowski; Rivera Is Director

April 12, 1991